Source: Journal of Pharmacology. Unidades: IME, FM
Subjects: PSIQUIATRIA, ANÁLISE ESTATÍSTICA DE DADOS
ABNT
DINIZ, Juliana Belo et al. Quetiapine versus clomipramine in the augmentation of selective serotonin reuptake inhibitors for the treatment of obsessive-compulsive disorder: a randomized, open-label trial. Journal of Pharmacology, v. 24, n. 3, p. 297-307, 2010Tradução . . Disponível em: https://doi.org/10.1177/0269881108099423. Acesso em: 15 nov. 2024.APA
Diniz, J. B., Shavitt, R. G., Pereira, C. A. de B., Hounie, A. G., Pimentel, I., Koran, L. M., et al. (2010). Quetiapine versus clomipramine in the augmentation of selective serotonin reuptake inhibitors for the treatment of obsessive-compulsive disorder: a randomized, open-label trial. Journal of Pharmacology, 24( 3), 297-307. doi:10.1177/0269881108099423NLM
Diniz JB, Shavitt RG, Pereira CA de B, Hounie AG, Pimentel I, Koran LM, Dainesi SM, Miguel EC. Quetiapine versus clomipramine in the augmentation of selective serotonin reuptake inhibitors for the treatment of obsessive-compulsive disorder: a randomized, open-label trial [Internet]. Journal of Pharmacology. 2010 ; 24( 3): 297-307.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1177/0269881108099423Vancouver
Diniz JB, Shavitt RG, Pereira CA de B, Hounie AG, Pimentel I, Koran LM, Dainesi SM, Miguel EC. Quetiapine versus clomipramine in the augmentation of selective serotonin reuptake inhibitors for the treatment of obsessive-compulsive disorder: a randomized, open-label trial [Internet]. Journal of Pharmacology. 2010 ; 24( 3): 297-307.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1177/0269881108099423